Viewing StudyNCT01286987



Ignite Creation Date: 2024-05-05 @ 11:13 PM
Last Modification Date: 2024-10-26 @ 10:30 AM
Study NCT ID: NCT01286987
Status: COMPLETED
Last Update Posted: 2019-01-10
First Post: 2011-01-26

Brief Title: Study of Talazoparib a PARP Inhibitor in Patients With Advanced or Recurrent Solid Tumors
Sponsor: Pfizer
Organization: Pfizer

Organization Data

Organization: Pfizer
Class: INDUSTRY
Study ID: PRP-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Pfizer
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Medivation Inc INDUSTRY